Center-Authored Papers

Filters: Author is Vessella, Robert  [Clear All Filters]
2008
Montgomery BR, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS.  2008.  Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.. Cancer research. 68(11):4447-54. Abstract
Lin B, Utleg AG, Gravdal K, White JT, Halvorsen OJ, Lu W, True LD, Vessella R, Lange PH, Nelson PS et al..  2008.  WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(5):1397-406. Abstract
2009
Qian DZ, Huang C-Y, O'Brien CA, Coleman IM, Garzotto M, True LD, Higano CS, Vessella R, Lange PH, Nelson PS et al..  2009.  Prostate cancer-associated gene expression alterations determined from needle biopsies.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(9):3135-42. Abstract
2010
Montgomery B, Nelson PS, Vessella R, Kalhorn T, Hess D, Corey E.  2010.  Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer.. BMC cancer. 10:244. Abstract
2011
Wright JL, Kwon EM, Ostrander EA, Montgomery BR, Lin DW, Vessella R, Stanford JL, Mostaghel EA.  2011.  Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(4):619-27. Abstract
Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, Pinna CMA, Hubaud A, Stadler B, Choi M, Bar M et al..  2011.  HIF induces human embryonic stem cell markers in cancer cells.. Cancer research. 71(13):4640-52. Abstract
2013
Qu X, Randhawa G, Friedman C, Kurland BF, Glaskova L, Coleman I, Mostaghel E, Higano CS, Porter C, Vessella R et al..  2013.  A Three-Marker FISH Panel Detects More Genetic Aberrations of AR, PTEN and TMPRSS2/ERG in Castration-Resistant or Metastatic Prostate Cancers than in Primary Prostate Tumors.. PloS one. 8(9):e74671. Abstract
Chang K-H, Li R, Kuri B, Lotan Y, Roehrborn CG, Liu J, Vessella R, Nelson PS, Kapur P, Guo X et al..  2013.  A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.. Cell. 154(5):1074-84. Abstract
Qu X, Randhawa G, Friedman C, O'Hara-Larrivee S, Kroeger K, Dumpit R, True L, Vakar-Lopez F, Porter C, Vessella R et al..  2013.  A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer.. Cancer genetics. 206(1-2):1-11. Abstract
Tamae D, Byrns M, Marck B, Mostaghel EA, Nelson PS, Lange P, Lin D, Taplin M-E, Balk S, Ellis W et al..  2013.  Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum.. The Journal of steroid biochemistry and molecular biology. 138C:281-289. Abstract
2014
Mostaghel EA, Nelson PS, Lange P, Lin DW, Taplin ME, Balk S, Ellis W, Kantoff P, Marck B, Tamae D et al..  2014.  Targeted androgen pathway suppression in localized prostate cancer: a pilot study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(3):229-37. Abstract
2015
Zhang X, Coleman I, Brown LG, True LD, Kollath L, Lucas JM, Lam H-M, Dumpit R, Corey E, Chéry L et al..  2015.  SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Yu S-H, Zheng Q, Esopi D, Macgregor-Das A, Luo J, Antonarakis ES, Drake CG, Vessella R, Morrissey C, De Marzo AM et al..  2015.  A Paracrine Role for IL-6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells.. Cancer immunology research. Abstract
2016
Wu Y, Davison J, Qu X, Morrissey C, Storer B, Brown L, Vessella R, Nelson P, Fang M.  2016.  Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer.. Epigenetics. 11(4):247-258. Abstract
Lam H-M, McMullin R, Nguyen H, Coleman I, Gormley M, Gulati R, Brown L, Holt S, Li W, Ricci DS et al..  2016.  Characterization of an abiraterone ultraresponsive phenotype in castration-resistant prostate cancer patient-derived xenografts.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract